L-Arginine and Nitric Oxide in CNS Function and Neurodegenerative Diseases

Critical Reviews in Food Science and Nutrition

Volumn 53, Issue 11, 2013, Pages 1157-1167

  Virarkar, Mayur ^a   Alappat, Lini ^a   Bradford, Peter G ^a   Awad, Atif B ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Alzheimer's disease; L arginine; neurodegenerative disease; nitric oxide; Parkinson's disease

Indexed keywords

ALZHEIMER'S DISEASE; CENTRAL NERVOUS SYSTEMS; CEREBRAL BLOOD FLOW; L-ARGININE; LONG-TERM POTENTIATIONS; PARKINSON'S DISEASE; PATHOLOGICAL LEVEL; PHYSIOLOGICAL PROCESS;

AMINO ACIDS; NITRIC OXIDE; POSITIVE IONS; ARGININE; BLOOD VESSELS;

NEURODEGENERATIVE DISEASES;

ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALZHEIMER DISEASE; ANIMAL; BLOOD; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; DEGENERATIVE DISEASE; DIET; HUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; ANIMALS; ARGININE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; DIET; HUMANS; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PARKINSON DISEASE;

EID: 84884229471     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2011.573885     Document Type: Review

References (147)

1. Abdelgabar, A. and Sharma, J. 2003. Sleep disorders in Parkinson's disease. Int. J. Clin. Prac., 57 (9): 781 - 787.
2. 2+ release channel from oxidation induced activation. J. Biol. Chem., 272 (41): 25462 - 25467.
3. Ali, S. F., Imam, S. Z. and Itzhak, Y. 2005. Role of peroxynitrite in methamphetamine-induced dopaminergic neurodegeneration and neuroprotection by antioxidants and selective NOS inhibitors. Ann. N. Y. Acad. Sci., 1053: 97 - 98.
4. Allweis, C., Gibbs, M. E., Ng, K. T. and Hodge, R. J. 1984. Effects of hypoxia on memory consolidation: Implications for a multistage model of memory. Behav. Brain Res., 11 (2): 117 - 121.
5. Ashina, M., Bendtsen, L., Jensen, R. and Olesen, J. 2000. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain., 123 (Pt 9): 1830 - 1837.
6. Autret, A., Lucas, B, Mondon, K, Hommet, C, Corcia, P, Saudeau, D. and de Toffol, B. 2001. Sleep and brain lesions: A critical review of the literature and additional new cases. Neurophysiol. Clin., 31 (6): 356 - 375.
7. Barford, P. A, Blair, J. A, Eggar, C, Hamon, C, Morar, C. and Whitburn, S.B. 1984. Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type. J. Neurol. Neurosurg. Psychiatry., 47 (7): 736 - 738.
8. Bode-Boger, S. M, Boger, R. H, Alfke, H, Heinzel, D, Tsikas, D, Creutzig, A, Alexander, K. and Frolich, J. C. 1996. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation., 93 (1): 85 - 90.
9. Bonifati, V, Rizzu, P, van Baren, M. J, Schaap, O, Breedveld, G. J, Krieger, E, Dekker, M. C, Squitieri, F, Ibanez, P, Joosse, M, van Dongen, J. W, Vanacore, N, van Swieten, J. C, Brice, A, Meco, G, van Duijn, C. M, Oostra, B. A. and Heutink, P. 2003. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science., 299 (5604): 256 - 259.
10. 2+ channel. Neuron., 18 (6): 951 - 958.
11. Bruckdorfer, R. 2005. The basics about nitric oxide. Mol. Aspects Med., 26 (1-2): 3 - 31.
12. Buguet, A, Gati, R, Sevre, J. P, Develoux, M, Bogui, P. and Lonsdorfer, J. 1989. 24 hour polysomnographic evaluation in a patient with sleeping sickness. Electroencephalogr. Clin. Neurophysiol., 72 (6): 471 - 478.
13. Buisson, A, Lakhmeche, N, Verrecchia, C, Plotkine, M. and Boulu, R. G. 1993. Nitric oxide: An endogenous anticonvulsant substance. Neuroreport., 4 (4): 444 - 446.
14. Burlet, S., Leger, L. and Cespuglio, R. 1999. Nitric oxide and sleep in the rat: A puzzling relationship. Neuroscience., 92 (2): 627 - 639.
15. Butterfield, D. A, Howard, B, Yatin, S, Koppal, T, Drake, J, Hensley, K, Aksenov, M, Aksenova, M, Subramaniam, R, Varadarajan, S, Harris-White, M. E, Pedigo, N. W. Jr. and Carney, J. M. 1999. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sci., 65 (18-19): 1883 - 1892.
16. Calabrese, V, Scapagnini, G, Ravagna, A, Bella, R, Foresti, R, Bates, T. E, Giuffrida Stella, A. M. and Pennisi, G. 2002. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J. Neurosci. Res., 70 (4): 580 - 587.
17. Calabrese, V, Mancuso, C, Calvani, M, Rizzarelli, E, Butterfield, D. A. and Stella, A. M. 2007. Nitric oxide in the central nervous system: Neuroprotection versus neurotoxicity. Nat. Rev. Neurosci., 8 (10): 766 - 775.
18. Calza, L., Giardino, L. and Ceccatelli, S. 1993. NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. Neuroreport., 4 (6): 627 - 630.
19. Ceccatelli, S. and Eriksson, M. 1993. The effect of lactation on nitric oxide synthase gene expression. Brain Res., 625 (1): 177 - 179.
20. Chen, L, Majde, J. A, Krueger, J. M, Chen, L, Majde, J. A. and Krueger, J. M. 2003. Spontaneous sleep in mice with targeted disruptions of neuronal or inducible nitric oxide synthase genes. Brain Res., 973 (2): 214 - 222.
21. Cynober, L. 2007. Pharmacokinetics of arginine and related amino acids. J. Nutr., 137 (6 SUPPL. 2): 1646S - 1649S.
22. Daff, S. 2010. NO synthase: Structures and mechanisms. Nitric Oxide., 23 (1): 1 - 11.
23. Danielson, S. R, Andersen, J. K, Danielson, S. R. and Andersen, J. K. 2008. Oxidative and nitrative protein modifications in Parkinson's disease. Free Radical Biol. Med., 44 (10): 1787 - 1794.
24. Danilov, A. I, Andersson, M, Bavand, N, Wiklund, N. P, Olsson, T. and Brundin, L. 2003. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J. Neuroimmunol., 136 (1-2): 112 - 118.
25. de la Torre, J. C. 2000. Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol. Aging., 21 (2): 331 - 342.
26. Delclaux, C, Malinvaud, D, Chevalier-Bidaud, B, Callens, E, Mahut, B. and and Bonfils, P. 2008. Nitric oxide evaluation in upper and lower respiratory tracts in nasal polyposis. Clin. Exp. Allergy., 38 (7): 1140 - 1147.
27. De Sarro, G, Di Paola, E. D, De Sarro, A. and Vidal, M. J. 1993. L-arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur. J. Pharmacol., 230 (2): 151 - 158.
28. Diaz, A., De Jesús, L., Mendieta, L., Calvillo, M., Espinosa, B., Zenteno, E., Guevara, J. and Limón, I. D. 2010. The amyloid-beta25-35 injection into the CA1 region of the neonatal rat hippocampus impairs the long-term memory because of an increase of nitric oxide. Neurosci. Lett., 468 (2): 151 - 155.
29. Edwards, T. M. and Rickard, N. S. 2002. Inhibition of monoADP-ribosylation prevents long-term memory consolidation of a single-trial passive avoidance task in the day-old chick. Neurobiol. Learn. Mem., 78 (1): 192 - 198.
30. Edwards, T. M. and Rickard, N. S. 2005. A scavenger of peroxynitrite prevents long-term memory formation using a single trial passive avoidance task for the day-old chick. Neurobiol. Learn. Mem., 83 (2): 163 - 167.
31. Edwards, T. M. and Rickard, N. S. 2007. New perspectives on the mechanisms through which nitric oxide may affect learning and memory processes. Neurosci. Biobehav. Rev., 31 (3): 413 - 425.
32. Evans, R. W, Fernstrom, J. D, Thompson, J, Morris, S. M. Jr. and Kuller, L. H. 2004. Biochemical responses of healthy subjects during dietary supplementation with L-arginine. J. Nutr. Biochem., 15 (9): 534 - 539.
33. Figueroa, A., Sanchez-Gonzalez, M. A., Perkins-Veazie, P. M. and Arjmandi, B. H. 2011. Effects of watermelon supplementation on aortic blood pressure and wave reflection in individuals with prehypertension: A pilot study. Am. J. Hypertens.,
34. Figueroa, A., Trivino, J. A., Sanchez-Gonzalez, M. A. and Vicil, F. 2010. Oral L-citrulline supplementation attenuates blood pressure response to cold pressor test in young men. Am. J. Hypertens., 23 (1): 12 - 16.
35. Fozard, J. R. 1995. The 5-hydroxytryptamine-nitric oxide connection: The key link in the initiation of migraine?. Arch. Int. de Pharmacodynamie et de Therapie., 329 (1): 111 - 119.
36. Fukuda, S, Hashimoto, N, Naritomi, H, Nagata, I, Nozaki, K, Kondo, S, Kurino, M. and and Kikuchi, H. 2000. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation., 101 (21): 2532 - 2538.
37. Furfine, E. S, Harmon, M. F, Paith, J. E, Knowles, R. G, Salter, M, Kiff, R. J, Duffy, C, Hazelwood, R, Oplinger, J. A. and Garvey, E. P. 1994. Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J. Biol. Chem., 269 (43): 26677 - 26683.
38. Galea, E. and Feinstein, D. L. 1999. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J., 13 (15): 2125 - 2137.
39. Garcia-Borreguero, D, Larrosa, O. and and Bravo, M. 2003. Parkinson's disease and sleep. Sleep Med. Rev., 7 (2): 115 - 129.
40. Gautier-Sauvigne, S, Colas, D, Parmantier, P, Clement, P, Gharib, A, Sarda, N. and and Cespuglio, R. 2005. Nitric oxide and sleep. Sleep Med. Rev., 9 (2): 101 - 113.
41. Gilchrist, M., Winyard, P. G. and Benjamin, N. 2010. Dietary nitrate-Good or bad?. Nitric Oxide., 22 (2): 104 - 109.
42. Gu, Y, Nieves, J. W, Stern, Y, Luchsinger, J. A. and and Scarmeas, N. 2010. Food combination and Alzheimer disease risk: A protective diet. Arch. Neurol., 67 (6): 699 - 706.
43. Guix, F. X, Uribesalgo, I, Coma, M. and Munoz, F. J. 2005. The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol., 76 (2): 126 - 152.
44. Gupta, S, Mehrotra, S, Villalon, C. M, Perusquia, M, Saxena, P. R. and and MaassenVanDenBrink, A. 2007. Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol. Therapeut., 113 (2): 321 - 340.
45. Hachinski, V. and Munoz, D. G. 1997. Cerebrovascular pathology in Alzheimer's disease: Cause, effect or epiphenomenon?. Ann. N. Y. Acad. Sci., 826: 1 - 6.
46. Hanggi, D. and Steiger, H. J. 2006. Nitric oxide in subarachnoid haemorrhage and its therapeutics implications. Acta Neurochir., 148 (6): 605 - 613. discussion 613
47. Hantraye, P, Brouillet, E, Ferrante, R, Palfi, S, Dolan, R, Matthews, R. T. and Beal, M. F. 1996. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med., 2 (9): 1017 - 1021.
48. Hars, B. 1999. Endogenous nitric oxide in the rat pons promotes sleep. Brain Res., 816 (1): 209 - 219.
49. Hart, J. D. and Dulhunty, A. F. 2000. Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding. J. Membr. Biol., 173 (3): 227 - 236.
50. Hawkins, R. A. and Hawkins, R. A. 2009. The blood-brain barrier and glutamate. Am. J. Clin. Nutr., 90 (3): 867S - 874S.
51. He, J, Wang, T, Wang, P, Han, P, Yin, Q. and and Chen, C. 2007. A novel mechanism underlying the susceptibility of neuronal cells to nitric oxide: The occurrence and regulation of protein S-nitrosylation is the checkpoint. J. Neurochem., 102 (6): 1863 - 1874.
52. Heneka, M. T, Wiesinger, H, Dumitrescu-Ozimek, L, Riederer, P, Feinstein, D. L. and and Klockgether, T. 2001. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J. Neuropathol. Exp. Neurol., 60 (9): 906 - 916.
53. Hirose, H, Ide, K, Sasaki, T, Takahashi, R, Kobayashi, M, Ikemoto, F, Yano, M. and and Nishikibe, M. 1995. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. [erratum appears in Eur J Pharmacol 1995 Sep 25;284(3):335-336]. Eur. J. Pharmacol., 277 (1): 77 - 87.
54. Holtz, M. L., Craddock, S. D. and Pettigrew, L. C. 2001. Rapid expression of neuronal and inducible nitric oxide synthases during post-ischemic reperfusion in rat brain. Brain Res., 898 (1): 49 - 60.
55. Hong, S. K., Maltz, B. E., Coburn, L. A., Slaughter, J. C., Chaturvedi, R., Schwartz, D. A. and Wilson, K. T. 2010. Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity. Inflamm Bowel. Dis., 16 (1): 105 - 111.
56. Ikeda, Y, Jimbo, H, Shimazu, M. and and Satoh, K. 2002. Sumatriptan scavenges superoxide, hydroxyl, and nitric oxide radicals: In vitro electron spin resonance study. Headache., 42 (9): 888 - 892.
57. Ishigami, A, Ohsawa, T, Hiratsuka, M, Taguchi, H, Kobayashi, S, Saito, Y, Murayama, S, Asaga, H, Toda, T, Kimura, N. and and Maruyama, N. 2005. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J. Neurosci. Res., 80 (1): 120 - 128.
58. Iversen, H. K., Olesen, J. and Tfelt-Hansen, P. 1989. Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain., 38 (1): 17 - 24.
59. Iwanishi, K, Watabe, H, Hayashi, T, Miyake, Y, Minato, K. and Iida, H. 2009. Influence of residual oxygen-15-labeled carbon monoxide radioactivity on cerebral blood flow and oxygen extraction fraction in a dual-tracer autoradiographic method. Ann. Nucl. Med., 23 (4): 363 - 371.
60. Izquierdo, L. A, Vianna, M, Barros, D. M, Mello e Souza, T, Ardenghi, P, Sant'Anna, M. K, Rodrigues, C, Medinam, J. H. and and Izquierdo, I. 2000. Short- and long-term memory are differentially affected by metabolic inhibitors given into hippocampus and entorhinal cortex. Neurobiol. Learn. Mem., 73 (2): 141 - 149.
61. Jenner, P, Dexter, D. T, Sian, J, Schapira, A. H. and Marsden, C. D. 1992. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurology., 32 (SUPPL.): S82 - S87.
62. Jouvet, M. 1972. The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Ergeb Physiol, 64: 166 - 307.
63. Kaiser, E, Schoenknecht, P, Kassner, S, Hildebrandt, W, Kinscherf, R. and and Schroeder, J. 2010. Cerebrospinal fluid concentrations of functionally important amino acids and metabolic compounds in patients with mild cognitive impairment and Alzheimer's disease. Neurodegener Dis., 7 (4): 251 - 259.
64. Kanamaru, K, Waga, S, Kojima, T, Fujimoto, K. and and Niwa, S. 1987. Endothelium-dependent relaxation of canine basilar arteries. Part 2: Inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke., 18 (5): 938 - 943.
65. Kanematsu, A, Yamamoto, S, Iwai-Kanai, E, Kanatani, I, Imamura, M, Adam, R. M, Tabata, Y. and Ogawa, O. 2005. Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. Am. J. Pathol., 166 (2): 565 - 573.
66. Kendrick, K. M, Guevara-Guzman, R, Zorrilla, J, Hinton, M. R, Broad, K. D, Mimmack, M. and and Ohkura, S. 1997. Formation of olfactory memories mediated by nitric oxide. Nature., 388 (6643): 670 - 674.
67. Kielstein, J. T, Donnerstag, F, Gasper, S, Menne, J, Kielstein, A, Martens-Lobenhoffer, J, Scalera, F, Cooke, J. P, Fliser, D. and Bode-Boger, S. M. 2006. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke., 37 (8): 2024 - 2029.
68. King, D. E., Mainous, A. G. and Geesey, M. E. 2008. Variation in L-arginine intake follow demographics and lifestyle factors that may impact cardiovascular disease risk. Nutr. Res., 28 (1): 21 - 24. 3rd
69. Kirkby, R. D, Carroll, D. M, Grossman, A. B. and and Subramaniam, S. 1996. Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res., 24 (2): 91 - 100.
70. Kleppisch, T. and and Feil, R. 2009. cGMP signalling in the mammalian brain: Role in synaptic plasticity and behaviour. Handb. Exp. Pharmacol.,: 549 - 579.
71. Knuckley, B, Causey, C. P, Jones, J. E, Bhatia, M, Dreyton, C. J, Osborne, T. C, Takahara, H. and Thompson, P. R. 2010. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. Biochemistry., 49 (23): 4852 - 463.
72. Lallement, G, Shih, T. M, Pernot-Marino, I, Baubichon, D, Foquin, A. and McDonough, J. H. 1996. The role of nitric oxide in soman-induced seizures, neuropathology, and lethality. Pharmacol. Biochem. Behav., 54 (4): 731 - 737.
73. Landis, B. N, Beghetti, M, Morel, D. R, Giger, R, Rimensberger, P. C. and Lacroix, J. S. 2003. Somato-sympathetic vasoconstriction to intranasal fluid administration with consecutive decrease in nasal nitric oxide. Acta Physiol. Scand., 177 (4): 507 - 515.
74. Lang, R. J, Harvey, J. R. and Mulholland, E. L. 2003. Sodium (2-sulfonatoethyl) methanethiosulfonate prevents S-nitroso-L-cysteine activation of Ca2+-activated K+ (BKCa) channels in myocytes of the guinea-pig taenia caeca. Brit. J. Pharmacol., 139 (6): 1153 - 1163.
75. Lassen, L. H, Ashina, M, Christiansen, I, Ulrich, V. and Olesen, J. 1997. Nitric oxide synthase inhibition in migraine. Lancet., 349 (9049): 401 - 402.
76. Leonard, T. O. and Lydic, R. 1997. Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate. J. Neurosci., 17 (2): 774 - 785.
77. Li, J, Billiar, T. R, Talanian, R. V. and Kim, Y. M. 1997. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun., 240 (2): 419 - 424.
78. Lopez-Figueroa, M. O., Itoi, K. and Watson, S. J. 1998. Regulation of nitric oxide synthase messenger RNA expression in the rat hippocampus by glucocorticoids. Neuroscience., 87 (2): 439 - 446.
79. Loscalzo, J. 2001. An experiment of nature: Genetic L-arginine deficiency and NO insufficiency. J. Clin. Invest., 108 (5): 663 - 664.
80. Lucotti, P. 2006. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am. J. Physiol. Endocrinol. Metab., 291 (5): E906 - E912.
81. Lucotti, P. 2009. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism., 58 (9): 1270 - 1276.
82. Luiking, Y. C, Engelen, M. P. and Deutz, N. E. 2010. Regulation of nitric oxide production in health and disease. Curr. Opin. Clin. Nutr. Metab. Care., 13 (1): 97 - 104.
83. Lundberg, J. O. and Weitzberg, E. 2010. The biological role of nitrate and nitrite: The times they are a-changin'. Nitric Oxide., 22 (2): 61 - 63.
84. Luth, H. J, Holzer, M, Gartner, U, Staufenbiel, M. and Arendt, T. 2001. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: Evidence for an induction by amyloid pathology. Brain Res., 913 (1): 57 - 67.
85. Luth, H. J, Munch, G. and Arendt, T. 2002. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res., 953 (1-2): 135 - 143.
86. MacMicking, J. D, Willenborg, D. O, Weidemann, M. J, Rockett, K. A. and Cowden, W. B. 1992. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med., 176 (1): 303 - 307.
87. Malinski, T. 2007. Nitric oxide and nitroxidative stress in Alzheimer's disease. J. Alzheimers Dis., 11 (2): 207 - 218.
88. Manzoni, O. and Bockaert, J. 1993. Nitric oxide synthase activity endogenously modulates NMDA receptors. J. Neurochem., 61 (1): 368 - 370.
89. Marino, J, Cudeiro, J, Marino, J. and Cudeiro, J. 2003. Nitric oxide-mediated cortical activation: A diffuse wake-up system. J. Neurosci., 23 (10): 4299 - 4307.
90. Markesbery, W. R. and Carney, J. M. 1999. Oxidative alterations in Alzheimer's disease. Brain Pathol., 9 (1): 133 - 146.
91. May, A, Bahra, A, Buchel, C, Frackowiak, R. S. and Goadsby, P. J. 1998. Hypothalamic activation in cluster headache attacks. [see comment]. Lancet., 352 (9124): 275 - 278.
92. McQuade, L. E, Ma, J, Lowe, G, Ghatpande, A, Gelperin, A. and Lippard, S. J. 2010. Visualization of nitric oxide production in the mouse main olfactory bulb by a cell-trappable copper(II) fluorescent probe. Proc. Natl. Acad. Sci. U. S. A., 107 (19): 8525 - 8530.
93. Menniti, F. S, Faraci, W. S. and Schmidt, C. J. 2006. Phosphodiesterases in the CNS: Targets for drug development. Nat. Rev. Drug Discovery., 5 (8): 660 - 670.
94. Mohlake, P. and Whiteley, C. G. 2010. Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: Peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides. Mol. Neurobiol., 41 (2-3): 149 - 158.
95. Molina y Vedia, L, McDonald, B, Reep, B, Brune, B, Di Silvio, M, Billiar, T. R. and Lapetina, E. G. 1992. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. [erratum appears in J Biol Chem 1993 Feb 5;268(4):3016]. J. Biol. Chem., 267 (35): 24929 - 24932.
96. Monfort, P, Munoz, M. D, Kosenko, E. and Felipo, V. 2002. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase. J. Neurosci., 22 (23): 10116 - 10122.
97. Monti, J. M. and and Jantos, H. 2004. Microinjection of the nitric oxide synthase inhibitor L-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat. Prog. Neuro-Psychopharmacol Biol Psychiatry., 28 (2): 239 - 247.
98. Morley, J. E. 1996. Anorexia in older persons: Epidemiology and optimal treatment. Drugs & Aging., 8 (2): 134 - 155.
99. Muller, U. 1996. Inhibition of nitric oxide synthase impairs a distinct form of long-term memory in the honeybee, Apis mellifera. Neuron., 16 (3): 541 - 549.
100. Murphy, S. 2000. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS. GLIA., 29 (1): 1 - 13.
101. Murray, J, Taylor, S. W, Zhang, B, Ghosh, S. S. and Capaldi, R. A. 2003. Oxidative damage to mitochondrial complex I due to peroxynitrite: Identification of reactive tyrosines by mass spectrometry. J. Biol. Chem., 278 (39): 37223 - 37230.
102. Nakamura, T, Gu, Z. and Lipton, S. A. 2007. Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases. Aging Cell., 6 (3): 351 - 359.
103. Nandagopal, K., Dawson, T. M. and Dawson, V. L. 2001. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J.Pharmacol. Exp. Ther., 297 (2): 474 - 478.
104. Nelson, R. J, Demas, G. E, Huang, P. L, Fishman, M. C, Dawson, V. L, Dawson, T. M. and Snyder, S. H. 1995. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. [see comment]. Nature., 378 (6555): 383 - 386.
105. Newcombe, J, Uddin, A, Dove, R, Patel, B, Turski, L, Nishizawa, Y. and Smith, T. 2008. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol., 18 (1): 52 - 61.
106. Olesen, J, Friberg, L, Olsen, T. S, Iversen, H. K, Lassen, N. A, Andersen, A. R. and and Karle, A. 1990. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann. Neurology., 28 (6): 791 - 798.
107. Olesen, J, Thomsen, L. L, Lassen, L. H. and Olesen, I. J. 1995. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia., 15 (2): 94 - 100.
108. Olesen, J, Diener, H. C, Husstedt, I. W, Goadsby, P. J, Hall, D, Meier, U, Pollentier, S. and Lesko, L. M. 2004. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.[see comment]. N. Eng. J. Med., 350 (11): 1104 - 1110.
109. Olesen, J., Thomsen, L. L. and Iversen, H. 1994. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci., 15 (5): 149 - 153.
110. Osonoe, K, Mori, N, Suzuki, K. and Osonoe, M. 1994. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res., 663 (2): 338 - 340.
111. Palacino, J. J, Sagi, D, Goldberg, M. S, Krauss, S, Motz, C, Wacker, M, Klose, J. and Shen, J. 2004. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem., 279 (18): 18614 - 18622.
112. Pampliega, O, Domercq, M, Villoslada, P, Sepulcre, J, Rodriguez-Antiguedad, A. and Matute, C. 2008. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J. Neuroimmunol., 195 (1-2): 194 - 198.
113. Penix, L. P., Davis, W. and Subramaniam, S. 1994. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res., 18 (3): 177 - 184.
114. Pollock, J. S, Forstermann, U, Mitchell, J. A, Warner, T. D, Schmidt, H. H, Nakane, M. and Murad, F. 1991. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U. S. A., 88 (23): 10480 - 10484.
115. Pratico, D. and Pratico, D. 2002. Alzheimer's disease and oxygen radicals: New insights. Biochem. Pharmacol., 63 (4): 563 - 567.
116. Prendergast, M. A, Terry, A. V. Jr., Jackson, W. J. and Buccafusco, J. J. 1997. Nitric oxide synthase inhibition impairs delayed recall in mature monkeys. Pharmacol. Biochem. Behav., 56 (1): 81 - 87.
117. Pridgeon, J. W, Olzmann, J. A, Chin, L. S. and and Li, L. 2007. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. Plos Biol., 5 (7): e172
118. Przedborski, S, Chen, Q, Vila, M, Giasson, B. I, Djaldatti, R, Vukosavic, S, Souza, J. M, Jackson-Lewis, V, Lee, V. M. and and Ischiropoulos, H. 2001. Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Neurochem., 76 (2): 637 - 640.
119. Przegalinski, E., Baran, L. and Siwanowicz, J. 1996. The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci. Lett., 217 (2-3): 145 - 148.
120. Read, S. J. and Parsons, A. A. 2000. Sumatriptan modifies cortical free radical release during cortical spreading depression. A novel antimigraine action for sumatriptan?. Brain Res., 870 (1-2): 44 - 53.
121. Rickard, N. S., Ng, K. T. and Gibbs, M. E. 1998. Further support for nitric oxide-dependent memory processing in the day-old chick. Neurobiol Learn Mem., 69 (1): 79 - 86.
122. Riviere, S., Birlouez-Aragon, I. and Vellas, B. 1998. Plasma protein glycation in Alzheimer's disease. Glycoconj. J., 15 (10): 1039 - 1042.
123. Rouge, C, Des Robert, C, Robins, A, Le Bacquer, O, Volteau, C, De La Cochetiere, M. F. and Darmaun, D. 2007. Manipulation of citrulline availability in humans. Am. J. Physiol. Gastrointest Liver Physiol., 293 (5): G1061 - G1067.
124. Scott, G. S, Bowman, S. R, Smith, T, Flower, R. J. and and Bolton, C. 2007. Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-D-aspartate (NMDA) receptor activation. Biochem Pharmacol., 73 (2): 228 - 236.
125. Shah, P. and Shah, V. 2007. Arginine supplementation for prevention of necrotizing enterocolitis in preterm infants. Cochrane DataBase Syst Rev., (3): 1 - 20.
126. Souza, J. M, Giasson, B. I, Chen, Q, Lee, V. M. and and Ischiropoulos, H. 2000. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem., 275 (24): 18344 - 18349.
127. Stewart, P. A, Hayakawa, K, Akers, M. A. and Vinters, H. V. 1992. A morphometric study of the blood-brain barrier in Alzheimer's disease. Laboratory Investigation., 67 (6): 734 - 742.
128. Suo, Z, Su, G, Placzek, A, Kundtz, A, Humphrey, J, Crawford, F. and Mullan, M. 2000. A beta vasoactivity in vivo. Ann. N. Y. Acad. Sci., 903: 156 - 163.
129. Tassorelli, C, Blandini, F, Greco, R. and Nappi, G. 2004. Nitroglycerin enhances cGMP expression in specific neuronal and cerebrovascular structures of the rat brain. J. Chem. Neuroanatomy., 27 (1): 23 - 32.
130. Toda, N, Ayajiki, K. and Okamura, T. 2009. Cerebral blood flow regulation by nitric oxide: Recent advances. Pharmacol Rev., 61 (1): 62 - 97.
131. Toda, N., Ayajiki, K. and Okamura, T. 2009. Cerebral blood flow regulation by nitric oxide in neurological disorders. Can J. Physiol. Pharmacol., 87 (8): 581 - 594.
132. Toda, N. and Okamura, T. 1990. Possible role of nitric oxide in transmitting information from vasodilator nerve to cerebroarterial muscle. Biochem Biophy Res Commun., 170 (1): 308 - 313.
133. Ueta, Y, Levy, A, Chowdrey, H. S. and Lightman, S. L. 1995. Inhibition of hypothalamic nitric oxide synthase gene expression in the rat paraventricular nucleus by food deprivation is independent of serotonin depletion. J. Neuroendocrin., 7 (11): 861 - 865.
134. van der Kuy, P. H, Merkus, F. W, Lohman, J. J, ter Berg, J. W. and Hooymans, P. M. 2002. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: An open, pilot study.[see comment]. Cephalalgia., 22 (7): 513 - 519.
135. Ward, M. E, Toporsian, M, Scott, J. A, Teoh, H, Govindaraju, V, Quan, A, Wener, A. D, Wang, G, Bevan, S. C, Newton, D. C. and Marsden, P. A. 2005. Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. J. Clin. Invest., 115 (11): 3128 - 3139.
136. Wascher, T. C, Graier, W. F, Dittrich, P, Hussain, M. A, Bahadori, B, Wallner, S. and Toplak, H. 1997. Effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur. J. Clin. Invest., 27 (8): 690 - 695.
137. Wells, B. J., Mainous, A. G. and Everett, C. J. 2005. Association between dietary arginine and C-reactive protein. Nutrition., 21 (2): 125 - 130. 3rd
138. Westall, F. C. and Westall, F. C. 2008. A response to "Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis". J. Neuroimmun., 203 (1): 116 - 117.
139. Willenborg, D. O, Staykova, M, Fordham, S, O'Brien, N. and Linares, D. 2007. The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis. J. Neuroimmun., 191 (1-2): 16 - 25.
140. Willenborg, D. O., Staykova, M. A. and Cowden, W. B. 1999. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review. J. Neuroimmun., 100 (1-2): 21 - 35.
141. Willmot, M, Gray, L, Gibson, C, Murphy, S. and Bath, P. M. 2005. A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide., 12 (3): 141 - 149.
142. Wu, G, Bazer, F. W, Davis, T. A, Kim, S. W, Li, P, Marc Rhoads, J, Carey Satterfield, M, Smith, S. B, Spencer, T. E. and and Yin, Y. 2007. Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J. Nutr., 137 (12): 2680 - 2685.
143. Wu, G, Collins, J. K, Perkins-Veazie, P, Siddiq, M, Dolan, K. D, Kelly, K. A, Heaps, C. L. and Meininger, C. J. 2009. Arginine metabolism and nutrition in growth, health and disease. Amino Acids, 37 (1): 153 - 168.
144. Yamada, K, Hiramatsu, M, Noda, Y, Mamiya, T, Murai, M, Kameyama, T, Komori, Y, Nikai, T, Sugihara, H. and Nabeshima, T. 1996. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience., 74 (2): 365 - 374.
145. Zhang, Y., Li, N. and Yang, Z. 2010. Perinatal food restriction impaired spatial learning and memory behavior and decreased the density of nitric oxide synthase neurons in the hippocampus of adult male rat offspring. Toxicol. Lett., 193 (2): 167 - 172.
146. Zhou, L. and Zhu, D. Y. 2009. Neuronal nitric oxide synthase: Structure, subcellular localization, regulation, and clinical implications. Nitric Oxide., 20 (4): 223 - 230.
147. Zweier, J. L., Li, H., Samouilov, A. and Liu, X. 2010. Mechanisms of nitrite reduction to nitric oxide in the heart and vessel wall. Nitric Oxide., 22 (2): 83 - 90.